ABSTRACT This study was conducted to determine the effect of in ovo feeding of dextrin (Dext) and iodinated casein (IC) on hatch and early growth in broilers. Three experiments were conducted at a commercial hatchery using a commercial Inovoject TM system with treatments occurring in conjunction with vaccination at transfer from incubator to hatcher units (18.5 to 19 d embryonic development). In all 3 experiments, approximately 15,000 eggs (2,500 eggs per group) were treated and transferred to a single hatcher unit. Treatments in Exp. 1 consisted of buffered saline solution alone (Control, Cont) or a dextrin solution (Dext, 18% maltodextrin, 10% potato starch dextrin) containing zero, 80, 240, 720, or 2,160 μg IC/mL. The results of this initial experiment indicated that broiler chicks at hatch that received 240 and 720 μg IC/mL in Dext were heavier (P < 0.05) compared to the other treatment groups; there were no differences in hatchability between groups. Based on these findings, subsequent studies used treatments of zero, 240, and 480 μg/mL IC in Dext or Cont. In Exp. 2, hatch weights in all treatment groups were higher (P < 0.05) compared to those receiving Cont. In Exp. 3, chicks given Dext alone or 240 and 480 μg/mL in saline weighed less at hatch compared to the other treatment groups. However, chicks provided Dext alone in Exp. 3 had less weight loss after a 24-hour holding period compared to the other groups. All treatment groups exhibited greater weight gain from one to 10 d compared to the Cont group. The results indicate that in ovo feeding of broiler embryos with Dext containing 240 and 480 μg IC/mL may have beneficial effects on broiler hatch weights and early growth rate.
INTRODUCTION
In commercial hatcheries, chicks are vaccinated via an in ovo injection system that also can introduce nutrients to developing embryos in addition to the specific vaccine. Many studies have been conducted in order to improve vaccine efficacy and to enhance broiler embryogenesis and post-hatch performance with amino acids, carbohydrates, vitamins, stimulants, or hormones (Gore and Qureshi, 1997; Johnston et al., 1997; Henry and Burke, 1999; Kocamis et al., 1999 Kocamis et al., , 2000 Ohta et al., 1999; Jochemsen and Jeurissen, 2002; Tako et al., 2004; Uni et al., 2005; Foye et al., 2006; Kadam et al., 2008; Zhai et al., 2008; Keralapurath et al., 2010a,b) . When the desired solution is introduced into amniotic fluid, it can be swallowed, digested, and absorbed by the embryo before pipping; i.e., in ovo feeding (Uni et al., C 2005) . Amniotic delivery is an ideal method to provide very controlled levels of vaccines and in ovo feeding compounds individually and an excellent opportunity to promote neonatal health and performance.
Thyroid hormone is well known to stimulate growth and energy metabolism. Hypothyroid chicks treated with Triiodothyronine (T 3 ) showed an increase in DNA replication and nuclei number (King et al., 1987) . Thyroid hormone has a stimulatory effect on increasing the embryonic oxygen consumption rate as well as tissue mass and mitochondrial mass (Goglia et al., 2002) . Oxygen consumption is considered an indirect measurement or indicator of metabolism in the embryo (Kleiber, 1975) . Christensen and Bieller (1982) indicated that metabolic rates in poult embryos were associated with increases in both plasma T 3 and T 4 , and concluded that thyroid hormone stimulated hatch in turkey embryos. The researchers also concluded that low levels of thyroid hormone in turkey embryos may be associated with late embryonic mortality. Furthermore, thyroid hormone may play a role in maturation of the lung in avian embryos Goeringer, 1981, 1982) .
1473
Therefore, Christensen (1985) hypothesized that the hatchability improvement in turkey embryos that received exogenous thyroid hormone could be due to an increase of surfactant synthesis resulting from increased T 3 .
Iodinated casein, a thyromimetic, has long been recognized to have a stimulatory effect on metabolicactivity (Reineke et al., 1943; Reineke and Turner, 1945) and was used to induce molting without the need for withdrawal of feed (Kuenzel et al., 2005 ). An ideal protein for protein iodination is milk casein because of its abundance of tyrosine. Additionally, in ovo injection of thyroid-related hormones into turkey embryos improved hatchability by 3 to 9% (Christensen and Bieller, 1982; Christensen, 1985) . Based on these studies, a study was conducted to determine if iodinated casein would improve hatchability in turkeys (Bottje et al., 2010) , and results indicated that a solution of dextrin-iodinated casein injected into turkey eggs on d 25 of incubation increased hatchability, hatch weights, and early growth of poults (Bottje et al., 2010) . The physiological effects of iodinated casein on hatchability, hatch weights, and production in broilers has not been determined, however. Uni et al. (2005) showed that administration of exogenous nutrients such as carbohydrate and β-hydroxy-β-methyl butyrate into the amnion of broiler embryos at 17 to 18 d of incubation replenished liver glycogen stores depleted during the prenatal period as well as increased hatch weight, BW, and breast muscle size, presumably by utilizing provided glycogen rather than muscle protein for energy. Similar results for glycogen replenishment have been observed in turkeys and ducks (Foye et al., 2006 (Foye et al., , 2007 .
From the discussion above, we hypothesized that providing a combination of dextrin and iodinated casein to broiler embryos in ovo may prevent early starvation and improve hatchability, hatch weight, and early chick growth. Therefore, the major objective of this study was to determine the effect of in ovo feeding of dextriniodinated casein on hatchability and early growth in broilers.
MATERIAL AND METHODS
Three experiments were conducted to determine the effect of dextrin-iodinated casein on hatch weight, hatchability, and BW. All egg injections were conducted at a commercial broiler hatchery. In Exp. 1, ∼15,000 eggs (2,520 eggs/treatment maximum) were injected with the buffered saline diluent used by the integrator as a Control (Cont) solution, or with iodinated casein (IC) in dextrin (Dext; 18% maltodextrin and 10% potato starch) with zero, 80, 240, 720, or 2,160 μg IC/mL. For Exp. 2 and 3, a 2 × 3 factorial design was used and consisted of in ovo injection of zero, 240, or 480 μg IC/mL in saline or Dext solutions. All in ovo solutions also contained gentamicin (10 μg/mL) and a commercial Marek's vaccine used by the hatchery.
Preparation of Solutions for In Ovo Feeding
Iodinated casein was prepared according to Kuenzel et al. (2005) with modifications (Bottje et al., 2010) . Briefly, 100 mL of distilled water containing 23.8 mg of manganese sulfate (MnSO 4; 2.8 mmoles/mL) and 2.25 g sodium bicarbonate (NaHCO 3; 154 mmoles/mL) were heated to 40
• C, and 6.75 g casein were slowly added to this solution with gentle stirring. Following this step, 1.24 g potassium iodide (KI; 8.7 mmoles) were added and heated in a water bath at 70
• C overnight (∼20 to 24 h). Iodinated casein was added to achieve the final target concentration of 240 and 480 μg/mL. Iodinated casein mixture was added to one liter of a solution containing 10 mg/mL gentamicin and a carbohydrate solution composed of 18% maltodextrin and 10% potato starch dextrin (∼280 mOsm). All other treatments received a commercial Marek's vaccine. All chemicals were obtained from Sigma Chemical Co., St. Louis MO.
Eggs and Egg Injections. Eggs were obtained from a mature breeder flock that was 24, 26, or 28 wk old in Exp. 1, 2, and 3, respectively. The injections were conducted during transfer from incubator to hatcher (∼d 18.5 to 19 embryonic development) using a commercial egg injector system (Inovoject TM system, Zoetis, Inc., Kalamazoo, MI). Candling was carried out automatically by the Inovoject system immediately prior to injection and non-fertile eggs were removed. The injection volume for all groups was 50 μL per egg. A maximum of 2,520 eggs was injected per treatment (168 eggs/basket x 15 hatching baskets) and all baskets were placed in a single hatcher unit.
Animals
Chick hatch weights and percent hatchability of fertile eggs after candling were obtained at the commercial hatchery for Exp. 1 and 2. In Exp. 3, after obtaining hatch weights, 600 chicks (100/treatment) were randomly selected and transported to the University of Arkansas poultry research farm. The chicks in Exp. 3 were neck-tagged and individually weighed, followed by a 24-hour holding period in boxes (100/box) to simulate time of transport and placement. After this period, chicks were placed in a single co-mingled litter floor pen and provided a standard starter diet ad libitum. Twenty marked seeder chicks from each group were challenged with 1,000 CFU/bird of Salmonella Enteritidis PT13A to simulate a mild natural Enterobacteriaceae pathogen load in poultry litter of commercial housing conditions. Chicks were brooded under standard conditions and weighed at one, 3, and 10 days. After 72 h post hatch, blood samples were collected for serum analysis (10 chicks/treatment). All procedures were approved by the University of Arkansas animal care and use committee (protocol #15005 and #11045).
Statistical Analysis
Data were anlyzed using one-and two-way ANOVA procedures using GraphPad Prism Statistical software (GraphPad Software Inc, La Jolla, CA). Chi-squared test was applied to analyze mortality and hatchability data. The percentages data were transformed by the function arcsine square root (ArcSin Sqrt, Variable/100) and final data are presented as natural numbers. The significant differences among treatment means were determined by Tukey's multiple comparison test. In Experiment 3, t-tests corrected for multiple comparisons by the Holm-Sidak method (Holm, 1979; Glantz, 2012) were used to determine differences between means -a procedure recommended when a significant interaction was obtained (in this case between d after hatch and treatment). All measures of statistical significance were based on a probability of P ≤ 0.05 unless otherwise stated.
RESULTS
In Exp. 1, hatch weights of all treatments were heavier (P < 0.05) than the Cont group, which was 36.6 ± 0.3 g, with the exception of the Dext IC80 group, and the highest hatch weights were observed in chicks that received the Dext IC240 and 720 μg/mL treatments (Table 1 ). The percentage hatch of fertile eggs in Exp. 1 was lower (P < 0.05) in the group receiving dextrin alone when compared to all groups (Table 1 ). Of the treatments tested, Dext IC240 did not have a negative impact on hatchability and significantly increased hatch weight, thus it was chosen for subsequent experiments. In addition, Dext plus 480 μg IC/mL was tested in Exp. 2 and 3 as a 2-fold dose of Dext IC240 and an intermediate level between Dext IC240 and Dext IC720. In Exp. 2, hatch weights were higher in all groups compared to Cont and the highest hatch weights observed Table 1 . Effect of in ovo feeding of saline (Control, Cont) and dextrin (Dext) with or without iodinated casein (IC 0, 80, 240, 720, 2,160 μg/ml) at transfer from incubator to hatcher (18.5 d embryonic development) on hatch weights (g) and percent hatchability of broiler chicks (from 24-week-old flock) in Exp. 1. in the IC480 group (Table 2 ). There were no differences in hatch of fertile among all groups for this study.
The results of Exp.3 are presented in Tables 3 and 4 . An increase in percent hatchability was observed in the Dext IC480 group at 99.0 ± 0.05%, compared to those receiving Dext alone at 96.0 ± 0.01%, but there were no other differences among all other groups (Table 3) . However, hatch weights were higher in the Cont, Dext IC240, and Dext IC480 groups compared to the Dext, IC240, and IC480 groups (Table 3 ). The effect of in ovo treatment on BW and BW gain through 10 d of age in Exp. 3 are shown in Table 4A and B, respectively. On d of hatch (d 0), and after a 24-hour holding period (d 1), chicks receiving the Cont or IC480, Dext IC240, and Dext IC480 by in ovo administration were heavier (P < 0.05) than the Dext or IC240 groups (Table 4A) . By d 10, however, broiler chicks that received Dext, IC480 and Dext IC480 were heavier than the Cont and Dext IC240 groups. Chicks receiving Dext alone in ovo exhibited the least BW loss during the 24-hour holding period (d 1-d 0; Table 4B ). Chicks that received Dext, IC480, and Dext IC480 treatments in ovo had higher (P < 0.05) BW gains between d 3 and d 1, d 10 and d 3, and d 10 and d 1 compared to Cont (Table 4B) . Salmonella colonization after challenge was confirmed, but there were no differences in detection of Salmonella in ceca following exposure of Salmonella positive chicks among treatment groups (data not shown). 
DISCUSSION
In ovo feeding of iodinated casein with or without dextrin to broiler embryos at the time of transfer to hatcher units (∼18.5 to 19 d embryonic development) improved hatch weight in 2 out of 3 experiments and early growth performance through 10 d post hatch in Exp. 3. These results are similar to effects previously reported in turkey poults (Bottje et al., 2010) . Improvement in hatchability and early growth observed in these studies may be due to thyromimetic proteins of iodinated casein. Increased amounts of satellite cells and skeletal muscle growth in response to early feeding immediately after hatch as a result of enhanced myoblast development in embryos has been reported (Uni et al., 2005) . A study by Halvey et al. (2003) showed that turkey poults exhibited increased amounts of satellite cells and skeletal muscle growth in response to early feeding immediately after hatch as a result of enhanced myoblast development in embryos. This effect could explain increased BW at 10 d in Exp. 3 in response to Dext IC480 treatment. The use of the nutrients added to a commercial diluent for the in ovo injection of broiler hatching eggs requires the use of appropriate levels to promote growth and nutrient utilization without adversely affecting hatchability (Kornasio et al., 2011) . Therefore, the optimum doses of iodinated casein (240 and 480 μg/mL) in Dext were established in Exp. 1. When administered with Dext, these levels did not adversely affect hatchability and increased hatch weights in Exp. 1 and 2. The reason for the decrease in hatchability with the Dext 0 μg/mL IC treatment in Exp. 1 is not clear.
Changes in the holding period (24 h) weight loss in response to injection of Dext may have been due to providing additional energy rather than relying on proteolysis of muscle for energy (Uni et al., 2005) . Studies with broilers and turkeys reported that early access to feed improved BW, size of pectoral muscles, and development of the intestinal tract Sklan, 1998, 1999; Uni et al., 1998a) . Chicks receiving an in ovo injection of Dext IC480 had the highest BW at d 3 and 10, which was similar to Tako et al. (2004) , who showed that in ovo injection of carbohydrate increased BW by 2.2% at d 10.
Increases in the BW of broiler embryos after in ovo administration of carbohydrate contributed to an enhancement of enteric development and subsequent enhancement in nutrient absorption (Tako et al., 2004) . The authors hypothesized that providing easily digested carbohydrate to the embryonic intestinal tissue at d 17.5, when the intestine typically has a low capacity to digest and absorb nutrients, may elevate activity of the relevant brush border enzymes, and supported this hypothesis with results showing an increase in maltase and sucrase activities at hatch in response to early carbohydrate nutrition (Uni et al., 2003b) . Villus surface area has been shown to be correlated with growth in chickens (Sklan, 2001) . Similar results from carbohydrate administration to in ovo embryos, which had 50% elevation in villus surface area before hatch, increased nutrient digestion and assimilation, enhanced enteric development, and resulted in increased BW at 10 d of age (Tako et al., 2004) . Thus, investigation of effects of dextrin with or without iodinated casein on intestinal morphology may be warranted.
Based on this discussion, it is reasonable to conclude that the improvement in hatchability and early growth observed in this study could be due to the ability of iodinated casein to stimulate metabolic activity similar to thyroid hormone and combined effects of providing carbohydrate as an energy source, thus increasing embryonic oxygen consumption rate as well as tissue mass and mitochondrial mass enhancement of myoblast development in embryos and the increase in villus surface area (Goglia et al., 2002; Tako et al., 2004; Uni et al., 2005) .
